Business
Australian government backs psychedelic drug clinical trials to treat mental illness – The Guardian
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
The use of magic mushrooms, ecstasy and other psychedelic drugs to treat mental illnesses, including depression and post-traumatic stress disorder, may be a step closer in Australia, with clinical trials given a $15m grant.
Despite international evidence suggesting the medicinal effectiveness of psychedelic drugs to treat mental health conditions, the Australian Therapeutic Drug Association last month made an interim decision against rescheduling MDMA and psilocybin from a prohibited substance (schedule…
-
Noosa News24 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business23 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares
-
Business21 hours agoHow to build a million-dollar ASX share portfolio in 25 years
-
General21 hours agoLabor’s socialist bedroom tax | The Spectator Australia